Cell and gene therapies are progressing through clinical trials and driving towards commercialization at a rapid pace. As a result, regulatory agencies have had to pivot quickly to provide guidance to support the pace of development.

Based on extensive experience supporting early-stage and clinical-stage companies through the drug development and approval process, the webinar will provide critical guidance for navigating regulatory requirements to accelerate the commercialization process and get much-needed therapies to patients sooner.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.